Your session is about to expire
← Back to Search
AN-BP for Esophageal Cancer
N/A
Waitlist Available
Led By Dennis J Gibson, MD
Research Sponsored by Denver Health and Hospital Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Summary
To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors
Eligible Conditions
- Esophageal Cancer
- Eating Disorders
- Barrett's Esophagus
- Rumination Syndrome
- Anorexia Nervosa
- Vomiting
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of patients positive for BE
Trial Design
1Treatment groups
Experimental Treatment
Group I: AN-BPExperimental Treatment1 Intervention
individuals with a dx of AN-BP, with a \>5-year history of purging, with a frequency of at least once a day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EsoGuard
2020
N/A
~150
Find a Location
Who is running the clinical trial?
Lucid Diagnostics, Inc.Industry Sponsor
6 Previous Clinical Trials
1,727 Total Patients Enrolled
Denver Health and Hospital AuthorityLead Sponsor
104 Previous Clinical Trials
402,096 Total Patients Enrolled
Dennis J Gibson, MDPrincipal InvestigatorDenver Health and Hospital Authority
Share this study with friends
Copy Link
Messenger